Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Novo-Nordisk
Company Monitoring Page for Novo-Nordisk
latest headlines for company on cafepharma
Novo Nordisk commences fresh trials for CagriSema
Devdiscourse
Thu, 01/30/25 - 11:33 am
Tags:
Novo Nordisk
,
CagriSema
,
clinical trials
,
obesity
FDA approves new indication for Ozempic to lower kidney risks in type 2 diabetes, CKD
Healio
Tue, 01/28/25 - 09:42 pm
Tags:
Novo Nordisk
,
FDA
,
Ozempic
,
kidney disease
Veru's drug conserves muscle mass for older patients taking Novo's Wegovy in phase 2 trial
Fierce Biotech
Tue, 01/28/25 - 10:17 am
Tags:
Veru
,
obesity
,
Novo Nordisk
,
enobosarm
Minnesota AG announces Novo Nordisk settlement capping monthly insulin payments at $35
MSN/Reuters
Mon, 01/27/25 - 10:51 pm
Tags:
Minnesota
,
Novo Nordisk
,
insulin
,
drug pricing
Novo Nordisk links next-gen obesity drug to 22% weight loss at Week 36, sending stock up 11%
Fierce Biotech
Fri, 01/24/25 - 11:47 am
Tags:
Novo Nordisk
,
amycretin
,
obesity
,
clinical trials
Novo Nordisk gets BACH1, inking IMMvention deal to orchestrate attack on sickle cell disease
Fierce Biotech
Wed, 01/22/25 - 11:55 am
Tags:
Novo Nordisk
,
sickle cell disease
,
IMMvention Therapeutix
Large study of Novo, Lilly weight loss drugs shows decrease in risk of Alzheimer's
Fierce Pharma
Tue, 01/21/25 - 07:13 pm
Tags:
Novo Nordisk
,
Eli Lilly
,
GLP-1 agonists
,
Wegovy
,
Ozempic
,
Zepbound
,
Mounjaro
,
Alzheimer's disease
,
arthritis
Novo Nordisk touts 'superior' weight loss results in study of high-dose Wegovy
Fierce Pharma
Fri, 01/17/25 - 11:34 am
Tags:
Novo Nordisk
,
obesity
,
semaglutide
,
Wegovy
,
Eli Lilly
,
Zepbound
,
clinical trials
Ozempic tops new Medicare price negotiation list
Pharmaphorum
Fri, 01/17/25 - 11:10 am
Tags:
Novo Nordisk
,
Ozempic
,
Wegovy
,
Rybelsus
,
HHS
,
Inflation Reduction Act
,
Medicare
5 questions facing pharma in 2025
BioPharma Dive
Fri, 01/10/25 - 11:47 am
Tags:
Donald Trump
,
obesity
,
Novo Nordisk
,
Eli Lilly
,
vaccines
,
pharma stocks
,
regulatory
,
immunology
Launches from Novo, Lilly top Clarivate's annual 'Drugs to Watch' list
Fierce Pharma
Wed, 01/8/25 - 11:20 pm
Tags:
Novo Nordisk
,
Awiqli
,
insulin
,
CagriSema
,
Eli Lilly
,
Ebglyss
Novo Nordisk doubles down on Valo, betting $190M near-term to apply AI to obesity and diabetes
Fierce Biotech
Wed, 01/8/25 - 11:23 am
Tags:
Novo Nordisk
,
Valo Health
,
artificial intelligence
,
diabetes
,
obesity
Novo Nordisk and Variant set out to find new metabolic treatments, pay communities that share genetic data
Fierce Biotech
Tue, 01/7/25 - 11:37 am
Tags:
Novo Nordisk
,
Variant Bio
,
metabolic disorders
,
drug discovery
Novo asks FDA to restrict Victoza compounding amid GLP-1 outsourcing row
Fierce Pharma
Sun, 01/5/25 - 09:40 pm
Tags:
Novo Nordisk
,
Victoza
,
FDA
,
compounding
Use of diabetes and anti-obesity drugs surges nationwide
Axios
Fri, 01/3/25 - 10:07 am
Tags:
obesity
,
diabetes
,
Eli Lilly
,
Novo Nordisk
,
Ozempic
,
Wegovy
,
Mounjaro
,
Zepbound
,
GLP-1 agonist
10 clinical trials to watch in the first half of 2025
BioPharma Dive
Thu, 01/2/25 - 11:42 am
Tags:
clinical trials
,
Eli Lilly
,
cardiovascular disease
,
Arvinas
,
protein degradation
,
Vera Therapeutics
,
IgA nephropathy
,
Novarts
,
pelacarsen
,
Entyvio
,
IBD
,
Novo Nordisk
,
Alzheimer's disease
,
Beam Therapeutics
,
sickle cell disease
,
COMPASS Pathways
,
psychedelics
,
Moderna Therapeutics
,
Verve Therapeutics
,
high cholesterol
FDA approves drugs from Vertex, Novo, Bristol Myers to wrap 2024
BioPharma Dive
Thu, 01/2/25 - 11:35 am
Tags:
FDA
,
Vertex Pharmaceuticals
,
Novo Nordisk
,
Bristol Myers Squibb
,
Alyftrek
,
cystic fibrosis
,
Alhemo
,
hemophilia
,
Opdivo Qvantiq
,
solid tumors
Novo’s next-gen obesity drug misses expectations in closely watched trial
BioPharma Dive
Fri, 12/20/24 - 11:34 am
Tags:
Novo Nordisk
,
CagriSema
,
clinical trials
,
weight loss
Novo Nordisk taps Photys for $186M cardiometabolic collab
Fierce Biotech
Wed, 12/18/24 - 11:21 am
Tags:
Novo Nordisk
,
Photys
,
MASH
,
chronic kidney disease
A new GLP-1 opportunity for pharma: Supporting patients’ emotional barriers to weight loss
Pharmaphorum
Wed, 12/18/24 - 11:14 am
Tags:
patients
,
GLP-1 agonists
,
obesity
,
weight loss
,
Novo Nordisk
,
Eli Lilly
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.